Professor Maher Gandhi
Professor Maher Gandhi

View ResearcherID Page

Leukaemia Foundation Queensland Chair in Blood Cancer Research

Senior Staff Specialist, Department of Haematology, Princess Alexandra Hospital

Professor Maher Gandhi has established an international reputation studying immunity and identification of novel biomarkers in lymphoma. His research aims to understand the basis of lymphoma; to devise new treatments which are less toxic and more effective; to establish new biomarkers which will help determine the most effective treatment strategies and to monitor response and relapse and understand the development of lymphomas. Lymphomas studied include Hodgkin Lymphoma, PTLD, Diffuse Large B-cell Lymphoma, Follicular Lymphoma and virus associated lymphomas. A broad range of approaches are utilised including genomics, molecular and cellular biology techniques and functional immunoassays.

 

Maher Gandhi received his medical degree in the UK in 1989, and then trained as a haematologist, including a Fellowship in malignant haematology at Princess Margaret Cancer Centre, Toronto. He obtained a PhD in immunology at Cambridge University. In 2003 he moved to Brisbane, working as a Senior Staff Specialist in the Haematology / Oncology Department of the Princess Alexandra Hospital, and established his own laboratory group at QIMR. He is Chair of Laboratory Sciences for the Australasian Leukaemia and Lymphoma Group, won the prestigious Australian Society of Medical Research Clinical Research Award in 2010 and in 2012 took up the inaugural John McCaffrey Cancer Council of Queensland / Office of Health and Medical Research Clinical Research Fellowship. He was privileged to serve as Chair of the Metro South Human Research Ethics Committee between 2011-2014. In 2013 he was appointed Professor of Experimental Haematology, University of Queensland, and took up his current role Head of the Blood Cancer Research Laboratory at the Diamantina Institute in 2014.

 

 

Email: m.gandhi@uq.edu.au
Phone: +61 7 3443 8026

Non-invasive disease monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. David M Kurtz; Michael R Green; Scott V Bratman; Florian P Scherer; Chih Long Liu; Christian Kunder; Kazuhiro Takahashi; Cynthia Glover; Colm Keane; Shingo Kihira; Brendan Visser; Jason Callahan; Katie Kong ; Malek Faham; Karen S Corbelli; David B Miklos; Ranjana Advani; Ronald Levy; Rodney J Hicks; Mark S Hertzberg; Robert S Ohgami; Maher K Gandhi; Maximilian Diehn; Ash A Alizadeh. Blood. Accepted 04/04/2015
 
HLA class I associations with EBV(+) post-transplant lymphoproliferative disorder. Jones K, Wockner L, Thornton A, Gottlieb D, Ritchie DS, Seymour JF, Kumarasinghe G, Gandhi MKTranspl Immunol. 2015 Mar;32(2):126-30.

Fine mapping of the 15q21 region implicate TP53BP1 and B2M in the lymphomagenesis of Follicular and Diffuse Large B-Cell lymphomas. Carlos Aya-Bonilla, Emily Camilleri, Miles Benton, Larisa M Haupt, Paula Marlton, Rod A Lea, Maher K Gandhi and Lyn R. Griffiths.  Carcinogenesis & Mutagenesis. 2014 May 21;15:390.

In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL). Carlos A Aya-Bonilla, Emily Camiller, Larisa M Haupt, Rod A Lea, Maher K Gandhi and Lyn R Griffiths. BMC Genomics. 2014; 15(1): 390. 

A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns of EBV-association. S. E. K. Fink; M. K. Gandhi; J. Nourse; C. Keane; K. Jones; P. Crooks; K. Jöhrens; A. Korfel; H. Schmidt; S. Neumann; A. Tiede; U. Jäger; U. Dührsen; R. Neuhaus; M. Dreyling; K. Borchert; T. Südhoff; H. Riess; I. Anagnostopoulos; R. U. Trappe. American Journal of Transplantation. 2014 Nov;14(11):2577-87

A Multi-Centre, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of Fixed Dose Rituximab in Patients with Refractory, Relapsed or Chronic Idiopathic Thrombocytopenic Purpura (R-ITP1000 Study). Huyen Tran, Tim Brighton, Andrew Grigg, Simon McRae, Joanna Dixon, Daniel Thurley, Maher K. Gandhi,Matt Truman, Paula Marlton, and John Catalano. British Journal of Haematology. 2014 Oct;167(2):243-51.

Plasma microRNA are disease response biomarkers in classical Hodgkin Lymphoma. Kimberley Jones, Jamie P. Nourse, Colm Keane, Atul Bhatnagar, and Maher K. Gandhi. Clinical Cancer Research. 2014 Jan 1;20(1):253-64.

A new frontier in haematology - combining pharmacokinetics with pharmacodynamic factors to improve choice and dose of drug. David Arpon, Maher K. Gandhi, Jenny Martin. British Journal of Clinical Pharmacology.  2014 Aug;78(2):274-81.

The presence of KIR2DS5 confers protection against adult immune thrombocytopenia.  L A. Seymour, JP. Nourse, P Crooks, L Wockner, R Bird, H Tran & MK. Gandhi. Tissue Antigens. 2014 Mar;83(3):154-60.

FCY-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive post-transplant lymphoproliferative disorder.  Heiner Zimmermann, Theresa Weiland, Jamie Nourse, Maher Gandhi, Petra Reinke, Ruth Neuhaus, Mohsen Karbasiyan, Barbara Gärtner, Ioannis Anagnostopoulos, Hanno Riess, Ralf Trappe and Stephan Oertel Clinical and Developmental Immunology. Journal of Immunology Research. 2014;2014:264723.

Serum CD163 and TARC as circulating biomarkers in Hodgkin lymphoma. Kimberley Jones, Louise Seymour, Maher K. Gandhi. Book Chapter "Biomarkers in Disease: Methods, Discoveries and Applications." Accepted 2014.

CD4+Tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy Keane, Colm, Gill, Devinder, Vari, Frank, Cross, Donna, Griffiths, Lynn and Gandhi, Maher (2013) American Journal of Hematology88 4: 273-276.

High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non-hodgkin's lymphoma Aya-Bonilla, C., Green, M.R., Camilleri, E., Benton, M., Keane, C., Marlton, P., Lea, R., Gandhi, M.K. and Griffiths, L.R. (2013) Genes Chromosomes and Cancer52 5: 467-479.
 
Primary CNS posttransplant lymphoproliferative disease (PTLD): An international report of 84 cases in the modern era Evens A.M., Choquet S., Kroll-Desrosiers A.R., Jagadeesh D., Smith S.M., Morschhauser F., Leblond V., Roy R., Barton B., Gordon L.I., Gandhi M.K., Dierickx D., Schiff D., Habermann T.M. and Trappe R. (2013) American Journal of Transplantation13 6: 1512-1522.
 
The Epstein-Barr Virus microRNA BART11-5p targets the early B-cell transcription factor EBF1 Ross, Nathan, Gandhi, Maher K. and Nourse, Jamie P. (2013) American Journal of Blood Research3 3: 210-224.
 
Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma. Jones KL, Vari F, Keane C, Crooks P, Nourse JP, Seymour LA, Gottlieb D, Ritchie DS, Gill D, Gandhi MK. Clin Cancer Res. 2013 Feb 1;19(3):731-42. 
 
 
Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma Keane, C., Nourse, J. P., Crooks, P., Nguyen-Van, D., Mutsando, H., Mollee, P., Lea, R. A. and Gandhi, M. K. (2012) Internal Medicine Journal42 10: 1113-1119.
 
Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples Nourse, J.P., Crooks, P., Keane, C.., Nguyen-Van, D., Mujaj, S., Ross, N., Jones, K., Vari, F., Han, E., Trappe, R., Fink, S. and Gandhi, M.K. (2012) Journal of Virological Methods184 1-2: 46-54.
 
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors White, Robert E., Raemer, Patrick C., Naresh, Kikkeri N., Meixlsperger, Sonja, Pinaud, Laurie, Rooney, Cliona, Savoldo, Barbara, Coutinho, Rita, Boedoer, Csaba, Gribben, John, Ibrahim, Hazem A., Bower, Mark, Nourse, Jamie P., Gandhi, Maher K., Middeldorp, Jaap, Cader, Fathima Z., Murray, Paul, Muenz, Christian and Allday, Martin J. (2012) Journal of Clinical Investigation122 4: 1487-1502.
 
Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma Jones, Kimberley, Nourse, Jamie P., Keane, Colm, Crooks, Pauline, Gottlieb, David, Ritchie, David S., Gill, Devinder and Gandhi, Maher K. (2012) American Journal of Hematology87 3: 258-265.
 
High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease Mutsando, Howard, Fahim, Magid, Gill, Devinder S., Hawley, Carmel M., Johnson, David W., Maher, K. Gandhi, Marlton, Paula V., Mar Fan, Helen G. and Mollee, Peter N. (2012)  American Journal of Blood Research2 1: 66-70.
 
The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms Nourse, Jamie P., Lea, Rod, Crooks, Pauline, Wright, Gillian, Tran, Huyen, Catalano, John, Brighton, Tim, Grigg, Andrew, Marlton, Paula and Gandhi, Maher K. (2012) Blood Coagulation and Fibrinolysis,23 1: 45-50.
 
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8+ T-cell epitopes Do Nguyen-Van, Colm Keane, Erica Han, Kimberley Jones, Jamie P. Nourse, Frank Vari, Nathan Ross, Pauline Crooks, Olivier Ramuz, Michael Green, Lyn Griffith, Ralf Trappe, Andrew Grigg, Peter Mollee, Maher K. Gandhi. (2011) American Journal of Blood Research, 1(2):146-159.
 
A novel immunodeficiency disorder characterized by genetic amplification of interleukin 25 Green, M. R., Camilleri, E., Gandhi, M. K., Peake, J. and Griffiths, L. R. (2011) Genes and Immunity12 8: 663-666.
 
Optimizing tumor-targeting chimeric antigen receptor T cells in B-cell lymphoma patients Gandhi, M. and Jones, K. (2011)  Immunotherapy3 12: 1441-1443.
 
Broad-spectrum immunosuppression by classless monocytes in non-Hodgkin's lymphoma Vari, F. and Gandhi, M.K. (2011) Immunotherapy3 6: 723-726.
 
Epstein-Barr virus-related post-transplant lymphoproliferative disorders: Pathogenetic insights for targeted therapy Nourse, J. P., Jones, K. and Gandhi, M. K. (2011) American Journal of Transplantation11 5: 888-895.
 
Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma Green, Michael R., Aya-Bonilla, Carlos, Gandhi, Maher K., Lea, Rod A., Wellwood, Jeremy, Wood, Peter, Marlton, Paula and Griffiths, Lyn R. (2011)  Genes Chromosomes and Cancer50 5: 313-326.
 
Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders Jones, Kimberley, Nourse, Jamie P., Morrison, Leanne, Nguyen-Van, Do, Moss, Denis J., Burrows, Scott R. and Gandhi, Maher K. (2010) Blood116 13: 2245-2252.
 
Can a blood test monitor lymphoma? Jones, Kimberley and Gandhi, Maher K. (2010)  Leukemia and Lymphoma51 6: 957-959.
 
Fulminant infectious mononucleosis and recurrent epstein-barr virus reactivation in an adolescent Nourse, Jamie P., Jones, Kimberley, Dua, Ujjwal, Runnegar, Naomi, Looke, David, Schmidt, Chris, Tey, Siok-Keen, Kennedy, Glen and Gandhi, Maher K. (2010) Clinical Infectious Diseases50 6: e34-e37.
 
Sodium valproate in combination with ganciclovir induces lysis of EBV-infected lymphoma cells without impairing EBV-specific T-cell immunity Jones, K., Nourse, J., Corbett, G. and Gandhi, M. K. (2010) International Journal of Laboratory Hematology32 1p1: e169-e174.
 
Selective accumulation of virus-specific CD8(+) T cells within the peripheral blood stem cell compartment Singh, Sanjleena, van Hauten, Paulien, Jones, Kimberley, Grimmett, Karen, Mills, Anthony K. and Gandhi, Maher K. (2009) Blood114 9: 2001-2003.
 
Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: Are we there yet? Jones, Kimberley and Gandhi, Maher K. (2009)  Leukemia and Lymphoma50 5: 684-686.
 
High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma Green, Michael, Gandhi, Maher K, Camilleri, Emily, Marlton, Paula, Lea, Rod and Griffiths, Lyn (2009) Leukemia Research33 5: 731-734.
 
 
The role of Epstein-Barr virus in Richter syndrome Nourse, Jamie, Jones, Kimberley and Gandhi, Maher K. (2009) British Journal of Haematology144 4: 613-613.
 
Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NF kappa B activity in Follicular Lymphoma Green, Michael R., Gandhi, Maher K., Courtney, Mark J., Marlton, Paula and Griffiths, Lyn (2009) Leukemia Research33 12: 1699-1702.
 
Immunodeficiency-associated lymphomas Tran, Huy, Nourse, Jamie, Hall, Sara, Green, Michael, Griffiths, Lyn and Gandhi, Maher K. (2008) Blood Reviews22 5: 261-281.
 
A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation Hourigan, Matthew J., Doecke, James, Mollee, Peter N., Gill, Devinder S., Norris, Debra, Johnson, David W. and Gandhi, Maher K. (2008) British Journal of Haematology141 6: 904-907.
 
Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis Tran, Huy, Cheung, Catherine, Gill, Devinder, Dua, Ujjwal, Nourse, Jamie, Boyle, Richard and Gandhi, Maher K. (2008)  Nature Clinical Practice Oncology5 4: 234-238.
 
Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders Gandhi, M., Wilkie, G. M., Dua, U., Mollee, P., Grimmett, K., Williams, T., Whitaker, N., Gill, D. and Crawford, D. (2007) American Journal of Transplantation7 5: 1293-1299.
 
Epstein-Barr virus T-cell immunity despite rituximab Nehring, Angela K., Dua, Ujjwal, Mollee, Peter, Gill, Devinder, Grimmett, Karen, Khanna, Rajiv, Moss, Denis and Gandhi, Maher K. (2007) British Journal of Haematology136 4: 628-632.
 
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial Haque, T., Wilkie, G., Jones, M., Higgins, C., Urquhart, G., Wingate, P., Burns, D., McAulay, K., Turner, M., Bellamy, C., Amlot, P., Kelly, D., MacGilchrist, A., Gandhi, M., Swerdlow A. and Crawford, D. (2007) Blood110 4: 1123-1131.
 
Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma Gandhi, Maher K., Moll, Guido, Smith, Corey, Dua, Ujjwal, Lambley, Eleanore, Ramuz, Olivier, Gill, Devinder, Marlton, Paula, Seymour, John F. and Khanna, Rajiv (2007) Blood110 4: 1326-1329.
 
The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation Hourigan, M. J., Mollee, P. N., Gill, D. S., Doecke, J., Norris, D., Johnson, D. W. and Gandhi, M. K.. (2007) American Journal of Transplantation7 : 399-399.
 
The use of T-cell directed cellular therapies in Australia Moss, D.J., Khanna, R. and Gandhi, M. (2007) Cytotherapy93: 222-224.
 
Functional reversion of antigen-specific CD8(+) T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope Smith, Corey, Cooper, Leanne, Burgess, Melinda, Rist, Michael, Webb, Natasha, Lambley, Eleanore, Tellam, Judy, Marlton, Paula, Seymour, John F., Gandhi, Maher and Khanna, Rajiv (2006) Journal of Immunology177 7: 4897-4906.
 
Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma Wilson, W. M., Dua, U., Grigg, A. P. and Gandhi, M. K. (2006)  Leukemia & Lymphoma47 5: 871-876.
 
Epstein-Barr virus-associated lymphomas Gandhi, M. K. (2006) Expert Review of Anti-Infective Therapy4 1: 77-89.
 
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. and Khanna, R. (2006) Blood108 7: 2280-2289.
 
Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma Gandhi, M. K., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P. J., Prince, H. M., Wolf, M., Clarke, K., Underhill, C., Mills, T., Mollee, P., Gill, D., Marlton, P., Seymour, J. F. and Khanna, R. (2006) Clinical Cancer Research12 2: 460-464.
 
Viruses and lymphoma Gandhi, Maher K. and Khanna, Rajiv (2005) Pathology37 6: 420-433.
 
Follicular lymphoma: Time for a re-think? Gandhi, Maher K. and Marcus, Robert E. (2005) Blood Reviews19 3: 165-178.
 
Technology Insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies Khanna, Rajiv, Moss, Denis and Gandhi, Maher (2005) Nature Clinical Practice Oncology2 3: 138-149.
 
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments Gandhi, Maher K. and Khanna, Rajiv (2004) Lancet Infectious Diseases4 12: 725-738.
 
Epstein-Barr virus-associated Hodgkin's lymphoma Gandhi, Maher K., Tellam, Judy T. and Khanna, Rajiv (2004) British Journal of Haematology125 3: 267-281.
 
Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation Gandhi, MK, Wills, MR, Sissons, JGP and Carmichael, AJ (2003) Blood Reviews17 4: 259-264.
 
Late diversification in the clonal composition of human cytomegalovirus-specific CD8(+) T cells following allogeneic hemopoietic stem cell transplantation Gandhi, MK, Wills, MR, Okecha, G, Day, EK, Hicks, R, Marcus, RE, Sissons, JGP and Carmichael, AJ (2003) Blood102 9: 3427-3438.
 
Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study Gandhi, MK, Lekamwasam, S, Inman, I, Kaptoge, S, Sizer, L, Love, S, Bearcroft, PW, Milligan, TP, Price, CP, Marcus, RE and Compston, JE (2003)  British Journal of Haematology,121 3: 462-468.
 
Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: Analysis of the human cytomegalovirus-specific CD8(+) T cell response Wills, MR, Okecha, G, Weekes, MP, Gandhi, MK, Sissons, PJG and Carmichael, AJ (2002)  Journal of Immunology168 11: 5455-5464.
 
Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients Gandhi, MK, Egner, W, Sizer, L, Inman, I, Zambon, M, Craig, JIO and Marcus, RE (2001) Bone Marrow Transplantation28 8: 775-781.
 
A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations Coulthard, SA, Rabello, C, Robson, J, Howell, C, Minto, L, Middleton, PG, Gandhi, MK, Jackson, G, McLelland, J, O'Brien, H, Smith, S, Reid, MM, Pearson, ADJ and Hall, AG (2000)  British Journal of Haematology110 3: 599-604.
 
A comparison of CD34(+) cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis Gandhi, MK, Jestice, HK, Scott, MA, Bloxham, DM, Bass, G, Craig, JIO and Marcus, RE (1999)  Bone Marrow Transplantation24 4: 369-375.
 
The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients Gandhi, MK, Jestice, K, Scott, MA, Bloxham, D, Bass, G and Marcus, RE (1999) Bone Marrow Transplantation23 1: 9-13.
 
A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study Scott, MA, Gandhi, MK, Jestice, HK, Mahendra, P, Bass, G and Marcus, RE (1998) Bone Marrow Transplantation22 3: 273-276.
 
The Alder-Reilly anomaly in association with the myelodysplastic syndrome Gandhi, MK, Howard, MR and Hamilton, PJ (1996) Clinical and Laboratory Haematology18 1: 39-40.
 
An Unusual Case of Hypersomnolence Syndrome Gandhi, MK and Chandler, JE (1995) Clinical and Laboratory Haematology17 3: 247-250.
 
A Case of Transfusion-Acquired Hepatitis-C Wreghitt, TG, Gandhi, MK, Gray, JJ, Blagdon, J, Rankin, A and Coates, PB (1993) Clinical and Laboratory Haematology15 2: 141-144.
 
Inducing Remission in Drug-Resistant Acute Myeloid-Leukemia with Cyclosporine-a Gandhi, MK, Keidan, AJ, Rees, Jkh, Twentyman, P and Coates, PB (1993) Clinical and Laboratory Haematology15 3: 219-221.
 
 

 

  • Novel regulators of cellular immunity in Diffuse Large B-cell Lymphoma
  • The interaction between environmental and genetic factors in Hodgkin lymphoma
  • Prognostic and disease response biomarkers
  • Mechanisms of action of immune effector cells
  • The development and characterization of a novel laboratory model of B-cell differentiation and lymphomagenesis.

We are keen to take on enthusiastic postgraduate students for honours, masters, doctoral studies and medical students looking to expand their skills by undertaking an MPhil or PhD.  We provide opportunities and hands on training for students to develop a range of proficiencies in immunological and biological techniques, that are relevent for their future careers in the field of haematological malignancies.  

Frequently, opportunities are provided for students to travel to present their work at national and international conferences, and our students have an extremely high success rate in being selected for oral presentations.  

If you are interested in finding out more, please email the Professor Maher Gandhi and provide your CV and academic record.  

Students must fulfil standard University of Queensland entry requirements.  Overseas elective students are also encouraged to apply.

 

 

Impact of sequence variation on CD8+ effector T-cell responses (K Jones et al. Blood, 2010).  This data was presented by Kimberley Jones and resulted in her winning the Australian Society of Medical Research PhD award, 2010.